Cargando…
微滴数字PCR和Super-ARMS检测晚期肺腺癌患者血浆循环肿瘤DNA表皮生长因子受体基因突变的临床价值研究
BACKGROUND AND OBJECTIVE: The patients with advanced lung adenocarcinoma should select targeted drugs based on the type of tumor epidermal growth factor receptor (EGFR) gene mutation. However, it is difficult to collect tumor tissue of advanced lung adenocarcinoma, and some experts agree that periph...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049790/ https://www.ncbi.nlm.nih.gov/pubmed/32093452 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.02.03 |
Ejemplares similares
-
抗表皮生长因子受体和抗血管内皮生长因子药物在非小细胞肺癌治疗中的作用
por: LANGER, Corey, et al.
Publicado: (2010) -
表皮生长因子受体突变细胞系H1650耐药机制探讨
Publicado: (2012) -
表皮生长因子受体酪氨酸激酶抑制剂在晚期非小细胞肺癌一线治疗中的应用
Publicado: (2010) -
晚期非小细胞肺癌表皮生长因子受体基因突变情况和其对吉非替尼疗效的影响
Publicado: (2012) -
直接测序法和ARMS法检测非小细胞肺癌表皮生长因子受体基因突变的比较
Publicado: (2014)